KalVista Pharmaceuticals
KALV
#7066
Rank
โ‚น35.10 B
Marketcap
โ‚น710.31
Share price
3.34%
Change (1 day)
-26.88%
Change (1 year)

Earnings for KalVista Pharmaceuticals (KALV)

Earnings in 2024 (TTM): -โ‚น13.65 Billion

According to KalVista Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚น10.52 Billion a decrease over its 2022 earnings that were of -โ‚น9.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for KalVista Pharmaceuticals from 2014 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น13.65 Billion29.84%
2023 -โ‚น10.52 Billion16.76%
2022 -โ‚น9.01 Billion20.62%
2021 -โ‚น7.47 Billion79.87%
2020 -โ‚น4.15 Billion14.01%
2019 -โ‚น3.64 Billion98.95%
2018 -โ‚น1.83 Billion3.41%
2017 -โ‚น1.77 Billion-13.11%
2016 -โ‚น2.04 Billion1.3%
2015 -โ‚น2.02 Billion92.7%
2014 -โ‚น1.05 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น11.45 Billion-17.42%๐Ÿ‡บ๐Ÿ‡ธ USA